Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis

[1] Almansour NM(2022)Triple-negative breast Cancer: a brief review about Epidemiology, Risk factors, signaling pathways, treatment and role of Artificial Intelligence Front Mol Biosci 9 836417-9

[2] Nitiss KC(2014)Twisting and ironing: doxorubicin cardiotoxicity by mitochondrial DNA damage Clin Cancer Res 20 4737-67

[3] Nitiss JL(2022)Event-free survival with Pembrolizumab in Early Triple-negative breast Cancer N Engl J Med 386 556-9

[4] Schmid P(2014)DNA torsion, and chromatin dynamics Biochim Biophys Acta 1845 84-23

[5] Cortes J(2019)Doxorubicin-Induced Cancer Cell Senescence shows a Time Delay Effect and is inhibited by Epithelial-Mesenchymal Transition (EMT) Med Sci Monit 25 3617-9

[6] Dent R(2019)Different sensitivities of senescent breast cancer cells to immune cell-mediated cytotoxicity Cancer Sci 110 2690-75

[7] Pusztai L(2022)Doxorubicin-induced senescence in normal fibroblasts promotes in vitro tumour cell growth and invasiveness: the role of Quercetin in modulating these processes Mech Ageing Dev 206 111689-61

[8] McArthur H(2021)Mechanisms of Cellular Senescence: cell cycle arrest and Senescence Associated Secretory phenotype Front Cell Dev Biol 9 645593-36

[9] Kummel S(2015)The fate of chemoresistance in triple negative breast cancer (TNBC) BBA Clin 3 257-29

[10] Yang F(2018)Cancer secretome and inflammation: the bright and the dark sides of NF-kappaB Semin Cell Dev Biol 78 51-70

[1] Almansour NM(2022)Triple-negative breast Cancer: a brief review about Epidemiology, Risk factors, signaling pathways, treatment and role of Artificial Intelligence Front Mol Biosci 9 836417-9

[2] Nitiss KC(2014)Twisting and ironing: doxorubicin cardiotoxicity by mitochondrial DNA damage Clin Cancer Res 20 4737-67

[3] Nitiss JL(2022)Event-free survival with Pembrolizumab in Early Triple-negative breast Cancer N Engl J Med 386 556-9

[4] Schmid P(2014)DNA torsion, and chromatin dynamics Biochim Biophys Acta 1845 84-23

[5] Cortes J(2019)Doxorubicin-Induced Cancer Cell Senescence shows a Time Delay Effect and is inhibited by Epithelial-Mesenchymal Transition (EMT) Med Sci Monit 25 3617-9

[6] Dent R(2019)Different sensitivities of senescent breast cancer cells to immune cell-mediated cytotoxicity Cancer Sci 110 2690-75

[7] Pusztai L(2022)Doxorubicin-induced senescence in normal fibroblasts promotes in vitro tumour cell growth and invasiveness: the role of Quercetin in modulating these processes Mech Ageing Dev 206 111689-61

[8] McArthur H(2021)Mechanisms of Cellular Senescence: cell cycle arrest and Senescence Associated Secretory phenotype Front Cell Dev Biol 9 645593-36

[9] Kummel S(2015)The fate of chemoresistance in triple negative breast cancer (TNBC) BBA Clin 3 257-29

[10] Yang F(2018)Cancer secretome and inflammation: the bright and the dark sides of NF-kappaB Semin Cell Dev Biol 78 51-70